ORB-021 In Patients With Advanced Solid Tumors

Clinical trial NCT06607939 · RECRUITING

Trial details

NCT number: NCT06607939
Sponsor: Orionis Biosciences Inc
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Cancer

Start date: 2024-11-21
Primary completion: 2026-05-29
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.